National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 44826-44827 [2017-20490]
Download as PDF
44826
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
Place: Gaylord National Resort and
Convention Center, 201 Waterfront Street,
National Harbor, MD 20745.
Contact Person: Gabriel B Fosu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
MSC 7808, Bethesda, MD 20892, (301) 435–
3562, fosug@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Child Psychopathology and
Developmental Disabilities Study Section.
Date: October 19–20, 2017.
Time: 8:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaylord National Resort and
Convention Center, 201 Waterfront Street,
National Harbor, MD 20745.
Contact Person: Jane A DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Interventions and Mechanisms for
Addiction.
Date: October 19, 2017.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Marc Boulay, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, (301) 300–
6541, boulaymg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Risk Prevention and Social
Behavior.
Date: October 19, 2017.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Weijia Ni, Ph.D., Chief/
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100,
MSC 7808, Bethesda, MD 20892, 301–594–
3292, niw@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Child Psychopathology and
Developmental Disabilities.
Date: October 19, 2017.
Time: 12:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
VerDate Sep<11>2014
18:28 Sep 25, 2017
Jkt 241001
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 20, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20485 Filed 9–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Heart, Lung,
and Blood Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: October 24, 2017.
Open: 8:00 a.m. to 12:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 35A, Porter Building, 35A Convent
Drive, Room 640, Bethesda, MD 20892.
Closed: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 35A, Porter Building, 35A Convent
Drive, Room 640, Bethesda, MD 20892.
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities National Heart, Lung, and Blood
Institute National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, 301–435–0260, moenl@mail.nih.gov.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 20, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20491 Filed 9–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings of the NHLBI
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
CLTR Conflicts Meeting.
Date: October 26, 2017.
Time: 8:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\26SEN1.SGM
26SEN1
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: YingYing Li-Smerin, MD,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7184, Bethesda, MD 20892–
7924, 301–827–7942, lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Trial Pilot Studies (R34).
Date: October 26–27, 2017.
Time: 1:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: YingYing Li-Smerin, MD,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7184, Bethesda, MD 20892–
7924, 301–827–7942, lismerin@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 20, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–20490 Filed 9–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2017–0747]
Boston Area Maritime Security
Advisory Committee; Vacancies
Coast Guard, Department of
Homeland Security.
ACTION: Request for applications.
AGENCY:
This notice requests
individuals interested in serving on the
Boston Area Maritime Security
Committee (AMSC) to submit their
applications for membership, to the
Captain of the Port (COTP), Boston, MA.
DATES: Requests for membership should
reach the U.S. Coast Guard COTP
Boston October 26, 2017.
ADDRESSES: Applications for
membership should be submitted to the
Captain of the Port Boston at the
following address: Commander (sx),
USCG Sector Boston, 427 Commercial
Street, Boston, MA 02109 or by email to
Phillip.C.Smith@uscg.mil.
FOR FURTHER INFORMATION CONTACT: For
questions about submitting an
application or about the AMSC in
SUMMARY:
VerDate Sep<11>2014
18:28 Sep 25, 2017
Jkt 241001
general, contact Mr. Phillip C. Smith at
617–223–3008 or by email to
Phillip.C.Smith@uscg.mil.
SUPPLEMENTARY INFORMATION:
Authority
Section 102 of the Maritime
Transportation Security Act (MTSA) of
2002 (Pub. L. 107–295) added section
70112 to Title 46 of the U.S. Code, and
authorized the Secretary of the
Department in which the Coast Guard is
operating to establish Area Maritime
Security Advisory Committees for any
port area of the United States. (See 33
U.S.C. 1226, 1231; 46 U.S.C. chapter
701; 50 U.S.C. 191, 192; 33 CFR 1.05–
1, 6.01; Department of Homeland
Security Delegation No. 0170.1). Under
46 U.S.C. 70112(g)(1)(B), the Federal
Advisory Committee Act (FACA) does
not apply to AMSCs.
Boston AMSC Purpose
The AMSCs shall assist the Captain of
the Port in the development, review,
update, and exercise of the AMS Plan
for their area of responsibility. Such
matters may include, but are not limited
to: Identifying critical port
infrastructure and operations;
Identifying risks (threats,
vulnerabilities, and consequences);
Determining mitigation strategies and
implementation methods; Developing
strategies to facilitate the recovery of the
MTS after a Transportation Security
Incident; Developing and describing the
process to continually evaluate overall
port security by considering
consequences and vulnerabilities, how
they may change over time, and what
additional mitigation strategies can be
applied.
AMSC Composition
The composition of an AMSC, to
include the Boston AMSC, is prescribed
under 33 CFR 103.305. Pursuant to that
regulation, members may be selected
from the Federal, Territorial, or Tribal
government; the State government and
political subdivisions of the State; local
public safety, crisis management, and
emergency response agencies; law
enforcement and security organizations;
maritime industry, including labor;
other port stakeholders having a special
competence in maritime security; and
port stakeholders affect by security
practices and policies. Also, at least 7 of
the AMSC members must each have 5
or more years of experience related to
maritime or port security operations.
AMSC Membership
The Boston AMSC has 41 members
who represent Federal, State, local, and
industry stakeholders from
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
44827
Massachusetts. We are seeking to fill 11
positions with this solicitation.
Applicants may be required to pass an
appropriate security background check
prior to appointment to the committee.
Members’ terms of office will be for 5
years; however, a member is eligible to
serve additional terms of office.
Members will not receive any salary or
other compensation for their service on
an AMSC.
Request for Applications
Those seeking membership are not
required to submit formal applications
to the local Captain of the Port,
however, because we do have an
obligation to ensure that a specific
number of members have the
prerequisite maritime security
experience, we encourage the
submission of resumes highlighting
experience in the maritime and security
industries.
The Department of Homeland
Security does not discriminate in
selection of Committee members on the
basis of race, color, religion, sex,
national origin, political affiliation,
sexual orientation, gender identity,
marital status, disability and genetic
information, age, membership in an
employee organization, or other nonmerit factor. The Department of
Homeland Security strives to achieve a
widely diverse candidate pool for all of
its recruitment actions.
Dated: September 19, 2017.
C.C. Gelzer,
Captain, U.S. Coast Guard, Federal Maritime
Security Coordinator Boston.
[FR Doc. 2017–20483 Filed 9–25–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–3387–
EM; Docket ID FEMA–2017–0001]
Georgia; Amendment No. 2 to Notice of
an Emergency Declaration
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
This notice amends the notice
of an emergency declaration for the
State of Georgia (FEMA–3387–EM),
dated September 8, 2017, and related
determinations.
DATES: This amendment was issued
September 11, 2017.
FOR FURTHER INFORMATION CONTACT:
Dean Webster, Office of Response and
SUMMARY:
E:\FR\FM\26SEN1.SGM
26SEN1
Agencies
[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Pages 44826-44827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20490]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings of the NHLBI
Special Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; CLTR Conflicts Meeting.
Date: October 26, 2017.
Time: 8:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 44827]]
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD
20892-7924, 301-827-7942, lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Clinical Trial Pilot Studies (R34).
Date: October 26-27, 2017.
Time: 1:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD
20892-7924, 301-827-7942, lismerin@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 20, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20490 Filed 9-25-17; 8:45 am]
BILLING CODE 4140-01-P